Accéder au contenu
Merck

Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration.

Cell reports (2020-02-23)
Kelly Mulfaul, Ema Ozaki, Nilisha Fernando, Kiva Brennan, Kathleen R Chirco, Emma Connolly, Chris Greene, Arvydas Maminishkis, Robert G Salomon, Mikhail Linetsky, Riccardo Natoli, Robert F Mullins, Matthew Campbell, Sarah L Doyle
RÉSUMÉ

Retinal degeneration is a form of neurodegenerative disease and is the leading cause of vision loss globally. The Toll-like receptors (TLRs) are primary components of the innate immune system involved in signal transduction. Here we show that TLR2 induces complement factors C3 and CFB, the common and rate-limiting factors of the alternative pathway in both retinal pigment epithelial (RPE) cells and mononuclear phagocytes. Neutralization of TLR2 reduces opsonizing fragments of C3 in the outer retina and protects photoreceptor neurons from oxidative stress-induced degeneration. TLR2 deficiency also preserves tight junction expression and promotes RPE resistance to fragmentation. Finally, oxidative stress-induced formation of the terminal complement membrane attack complex and Iba1+ cell infiltration are strikingly inhibited in the TLR2-deficient retina. Our data directly implicate TLR2 as a mediator of retinal degeneration in response to oxidative stress and present TLR2 as a bridge between oxidative damage and complement-mediated retinal pathology.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
Kit de détection in situ de la mort cellulaire, rouge TMR, sufficient for ≤50 tests
Sigma-Aldrich
Anti-CFB antibody produced in rabbit, Ab3, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution